Abstract
Osteopetrosis is a rare metabolic bone disease, characterized by dysfunction of osteoclasts, resulting in increased bone density and brittleness leading to pathological fractures and bone deformities. Hip and knee osteoarthritis (OA) are common long-term complications in patients with osteopetrosis. Joint arthroplasty surgery remains an effective and recommended treatment for these patients with an end-stage OA because it provides favorable outcomes. However, in osteopetrosis, joint arthroplasty surgery carries an increased risk of complications, and specific preoperative and perioperative considerations are required to deal with the technical challenges related to the disease. The aim of this article was to review some of the key aspects of osteopetrosis, provide technical recommendations, and answer clinically relevant questions related to hip and knee arthroplasty surgery.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference42 articles.
1. Osteopetrosis. Current clinical considerations;Shapiro;Clin Orthop Relat Res,1993
2. Osteopetrosis;Stark;Orphanet J Rare Dis,2009
3. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030;Sloan;J Bone Joint Surg Am Vol,2018
4. Properties and origin of osteoblasts;Krzysztof;Clin Orthop,1990
5. Biology of RANK, RANKL, and osteoprotegerin;Boyce;Arthritis Res Ther,2007